Bill Sponsors: NJ A5101 | 2018-2019 | Regular Session

Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee [A5101 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Representative John Armato [D]PrimarySponsored BillsHD-002FollowTheMoneyBallotpediaVoteSmart
Representative Robert Karabinchak [D]PrimarySponsored BillsHD-018FollowTheMoneyBallotpediaVoteSmart

Social Comments on NJ A5101

feedback